Sol-Gel Technologies Price to Sales Ratio 2016-2023 | SLGL
Historical PS ratio values for Sol-Gel Technologies (SLGL) over the last 10 years. The current P/S ratio for Sol-Gel Technologies as of May 02, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Sol-Gel Technologies P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-05-03 |
0.85 |
|
14.39 |
| 2023-12-31 |
1.11 |
$0.06 |
18.69 |
| 2023-09-30 |
1.63 |
$0.06 |
25.52 |
| 2023-06-30 |
2.99 |
$0.07 |
44.29 |
| 2023-03-31 |
3.88 |
$0.20 |
19.58 |
| 2022-12-31 |
4.56 |
$0.17 |
27.16 |
| 2022-09-30 |
5.02 |
$1.07 |
4.71 |
| 2022-06-30 |
4.10 |
$1.43 |
2.87 |
| 2022-03-31 |
7.38 |
$1.32 |
5.61 |
| 2021-12-31 |
7.40 |
$1.35 |
5.50 |
| 2021-09-30 |
10.00 |
$0.53 |
18.69 |
| 2021-06-30 |
12.38 |
$0.25 |
48.76 |
| 2021-03-31 |
12.38 |
$0.26 |
47.07 |
| 2020-12-31 |
9.79 |
$0.39 |
24.80 |
| 2020-09-30 |
7.24 |
$0.51 |
14.21 |
| 2020-06-30 |
8.95 |
$0.66 |
13.64 |
| 2020-03-31 |
7.06 |
$1.02 |
6.93 |
| 2019-12-31 |
17.15 |
$1.19 |
14.39 |
| 2019-09-30 |
8.99 |
$0.99 |
9.12 |
| 2019-06-30 |
9.11 |
$0.75 |
12.16 |
| 2019-03-31 |
6.77 |
$0.34 |
19.91 |
| 2018-12-31 |
6.02 |
$0.01 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.024B |
$0.002B |
|
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
|
